Skip to main navigation Skip to search Skip to main content

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

  • European paediatric Soft tissue sarcoma Study Group

Research output: Contribution to journal › Article › peer-review

181 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Keyphrases